购物车
- 全部删除
- 您的购物车当前为空
Teglicar(亦称为ST1326)是一种针对肝脏异构体的肉碱棕榈酰转移酶1(L-CPT1)的选择性可逆抑制剂。它降低了酮体生成和葡萄糖产生,减少了糖异生作用,并改善了葡萄糖稳态。
Teglicar(亦称为ST1326)是一种针对肝脏异构体的肉碱棕榈酰转移酶1(L-CPT1)的选择性可逆抑制剂。它降低了酮体生成和葡萄糖产生,减少了糖异生作用,并改善了葡萄糖稳态。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | Teglicar (also known as ST1326) is a selective reversible inhibitor of carnitine palmitoyltransferase 1 (L-CPT1), the liver isoform. It reduces ketogenesis and glucose production, decreases gluconeogenesis, and enhances glucose homeostasis. |
别名 | Teglicar, ST-1326, ST1326, ST 1326, 4-trimethylammonio-TDCAB |
分子量 | 436.07 |
分子式 | C22H46ClN3O3 |
CAS No. | 908566-80-3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容